AI-Powered Company Profile innovativegummies.com

ILS Gummies Market Intelligence

350 Cypress Hill Dr. McKinney, TX 75071 Pharmaceuticals, Health, Wellness & Fitness Manufacturer

ILS Gummies operates in Pharmaceuticals, Health, Wellness & Fitness, functioning as Manufacturer, based in United States, founded in 2022.

4
Ingredients
1
Products
24
People Records
1
Certificates

AI Narrative Overview

ILS Gummies is active in Pharmaceuticals, Health, Wellness & Fitness, with 1 identified product association including ILS GUMMIES, and 3 ingredient links such as Lion'S Mane Mushroom Gummies, Master Blend Mushroom Gummies, operating from United States.

Ingredient Intelligence

ILS Gummies is linked to 3 ingredients: Lion'S Mane Mushroom Gummies, Master Blend Mushroom Gummies, Om Brain Fuel+ Mushroom Gummies. INCI names include Gelatin. CAS references: 9000-70-8, 9000-70-8.

Product Intelligence

ILS Gummies has 1 product record: ILS GUMMIES, under brands: INNOVATIVEGUMMIES, within the Pharmaceuticals ecosystem.

People Intelligence

ILS Gummies has 24 people records, including Chief Executive Officer/Co Founder, QC IPC, across Founder, Entry levels.

ILS Gummies Connected Intelligence Graph

This profile combines organization, product, ingredient, and narrative signals into a higher-fidelity company record.

Ingredient SignalsView all 4

Lion'S Mane Mushroom Gummies

Gelatin

CAS: 9000-70-8 · INCI: Gelatin

Master Blend Mushroom Gummies

Gelatin

CAS: 9000-70-8 · INCI: Gelatin

Om Brain Fuel+ Mushroom Gummies

Gelatin

CAS: 9000-70-8 · INCI: Gelatin

Product SignalsView all 1

ILS GUMMIES

Brand: INNOVATIVEGUMMIES · Industry: Pharmaceuticals

Market and Ecosystem Signals

Explore the full intelligence profile for ILS Gummies

People, products, ingredients, and market context for ILS Gummies in Pharmaceuticals, Health, Wellness & Fitness.

Start for free

Company Intelligence Questions

Data-backed questions about ILS Gummies in Pharmaceuticals, Health, Wellness & Fitness, United States.

29 questions
ILS Gummies is a Manufacturer in the Pharmaceuticals industry. It researches, develops, and delivers medicinal products — covering prescription drugs, OTC medicines, biologics, and specialty therapeutics. The company serves healthcare providers, hospital networks, retail pharmacies, and regulated distribution channels.
ILS Gummies has been operating since 2022. That experience reflects well-established R&D capabilities, deeper regulatory knowledge, and long-standing relationships with clinical partners and approved suppliers.
ILS Gummies is headquartered in 350 Cypress Hill Dr. McKinney. Operating location determines regulatory jurisdiction — US-based companies follow FDA frameworks, while others operate under EMA, WHO, or local health authority requirements.
ILS Gummies operates as a Manufacturer. Innovator companies develop and patent new drug compounds; generic manufacturers produce off-patent formulations; distributors supply products to pharmacy, hospital, and clinical channels. ILS Gummies may operate across more than one of these roles.
Visit nexusplatform.ai/company/details/innovativegummies.com for the complete profile — company type, key contacts, product range, therapeutic areas, and certifications, all in one place.
ILS Gummies is led by Andrew Riess, Chief Executive Officer/Co Founder. Leadership in pharmaceuticals typically comes from clinical research, regulatory affairs, medicinal chemistry, or commercial strategy — backgrounds that directly influence pipeline decisions and market positioning.
View Full Profile
Register for free to see full contact details, emails, 1 products, 3 ingredients and more for ILS Gummies.
Create Free Account
Already have an account? Sign in
Contact ILS Gummies

Fuel growth with unified, Trusted Data

  • No credit card required*

Pay only for what you use Plans start from $29

Global insights